Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advanced Drug Delivery Reviews|August 23, 2001
Polymeric lamellar substrate particles for intranasal vaccinationI Jabbal-Gill, W Lin, O Kistner, et al.
Vaccine|January 4, 2001
Humoral and cell-mediated immunity to vero cell-derived influenza vaccineP Brühl, A Kerschbaum, O Kistner, et al.
Molecular Cancer Therapeutics|September 4, 2008
Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from AfricansR Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
VASA. Supplementum|January 1, 1991
[Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities]T Weiss, J Griesshaber, W Rogatti, et al.
Vaccine|July 31, 1998
Development of a mammalian cell (Vero) derived candidate influenza virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Molecular Cancer Therapeutics|January 24, 2007
Effect of population and gender on chemotherapeutic agent-induced cytotoxicityRong Stephanie Huang, Emily O Kistner, Wasim K Bleibel, et al.
ALTEX|March 15, 2001
[Development of a novel influenza vaccine derived from a continuous cell line]O Kistner, N Barrett, W Mundt, et al.
Developments in Biological Standardization|September 24, 1999
Development of a Vero cell-derived influenza whole virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Transfusion|February 27, 2007
H5N1 influenza virus and the safety of plasma productsT R Kreil, U Unger, S M Orth, et al.
Wiener Klinische Wochenschrift|May 5, 1999
A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale productionO Kistner, P N Barrett, W Mundt, et al.
Pageof 5